Bioequivalence of Carbamazepine Chewable and Conventional Tablets: Single-Dose and Steady-State Studies
- 1 August 1985
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 74 (8), 866-870
- https://doi.org/10.1002/jps.2600740813
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Lactate dehydrogenase activity as measured by the SMAC is related to flow-cell energy.Clinical Chemistry, 1982
- Pharmacokinetics of carbamazepine in normal humans after single and repeated oral dosesJournal of Pharmacokinetics and Biopharmaceutics, 1976
- The use of confidence intervals in biopharmaceuticsJournal of Pharmacy and Pharmacology, 1976
- Pharmacokinetic Model to Describe Self‐Induced Decreases in Steady‐State Concentrations of CarbamazepineJournal of Pharmaceutical Sciences, 1976
- GLC Determination of Carbamazepine Suitable for Pharmacokinetic StudiesJournal of Pharmaceutical Sciences, 1975
- Plasma kinetics of carbamazepine and its epoxide metabolite in man after single and multiple dosesEuropean Journal of Clinical Pharmacology, 1975
- Metabolism and Pharmacokinetics of CarbamazepineDrug Metabolism Reviews, 1975
- Use of Confidence Intervals in Analysis of Comparative Bioavailability TrialsJournal of Pharmaceutical Sciences, 1972
- Report on the Anti‐Epileptic Action of TegretolEpilepsia, 1964
- TRIGEMINAL NEURALGIA: ITS TREATMENT WITH A NEW ANTICONVULSANT DRUG (G-32883)The Lancet, 1962